Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small molecules
Biotech
Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial
Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback, prompting the French drugmaker to pull back from monotherapy plans.
Nick Paul Taylor
Apr 24, 2025 4:46am
Empress' crown slips as biotech lays off over half of workers
Mar 18, 2025 1:20pm
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
Kronos lays off 83% of staff, changes CEO after clinical setback
Nov 27, 2024 9:56am
Lilly's lipoprotein-blocking heart drug posts midstage trial win
Nov 19, 2024 9:55am
Roche sparks $1.8B-plus discovery deal with Flare Therapeutics
Nov 12, 2024 7:00am
